• Multi-Omics Uncovers ARID1A-Driven Resistance in Melanoma

  2026-05-26

  This study integrates multi-omics to map drug response and resistance networks in BRAF-mutant melanoma, identifying ARID1A loss as a key driver of resistance to BRAF/MAPK inhibitors. The findings reveal actionable resistance nodes and signaling rewiring, offering new targets for improving the durability of melanoma therapies.

• PEDV Relies on Host IMPDH Activity: Insights from Metabolomi

  2026-05-26

  This study reveals that porcine epidemic diarrhea virus (PEDV) manipulates host nucleotide metabolism, specifically targeting IMPDH-dependent guanine biosynthesis to promote replication. The findings highlight IMPDH as a host-directed vulnerability, with both genetic and pharmacological inhibition—using Merimepodib (VX-497)—significantly suppressing viral replication.

• Heparin Sodium in Translational Research: Mechanisms & Innov

  2026-05-25

  This thought-leadership article provides translational researchers with an advanced perspective on the mechanistic action, experimental utility, and strategic frontiers of heparin sodium as a glycosaminoglycan anticoagulant. By bridging foundational anti-coagulant research with nanoparticle delivery systems and emerging insights from plant-derived nanovesicle studies, the article offers actionable protocol guidance, reviews the evolving competitive landscape, and projects the future of blood coagulation pathway research. The piece draws on recent peer-reviewed studies, expert protocols, and APExBIO product data to support decision-making in thrombosis modeling, anti-factor Xa activity assays, and activated partial thromboplastin time (aPTT) workflows.

• 2X Taq PCR Master Mix: Precision PCR for Genotyping & Clonin

  2026-05-25

  Unlock streamlined PCR workflows with the 2X Taq PCR Master Mix (with dye), designed for rapid DNA amplification and direct gel analysis. This ready-to-use master mix accelerates genotyping, TA cloning, and sequence validation—empowering translational research and troubleshooting at the bench.

• Plant Exosome-Like Nanovesicles Mitigate Sertoli Cell Injury

  2026-05-24

  This study demonstrates that exosome-like nanovesicles from Cistanche deserticola (CDELNs) alleviate cyclophosphamide-induced testicular injury by targeting cell cycle arrest in Sertoli cells. The findings reveal a novel miRNA-mediated mechanism with translational promise for male reproductive protection.

• HyperTrap Heparin HP Column: Redefining Affinity Purificatio

  2026-05-23

  Discover how the HyperTrap Heparin HP Column advances high-resolution affinity purification for complex biomolecules—including coagulation factors and nucleic acid enzymes. This deep dive explores its unique technical innovations and their impact on translational cancer research.

• PTEN mRNA Reinstatement: Mechanistic and Strategic Innovatio

  2026-05-22

  Explore the transformative role of EZ Cap™ Human PTEN mRNA (ψUTP) in overcoming PI3K/Akt-driven cancer resistance, with an emphasis on mechanistic rationale, translational research strategy, and the advancing frontier of mRNA-based tumor suppressor restoration. Drawing on recent nanoparticle-mediated delivery breakthroughs and practical protocol guidance, this article delivers actionable insights for researchers seeking robust, durable, and immunologically silent PTEN expression in cancer models.

• Dynamic LRIG1 Expression in Salivary Gland Development Revea

  2026-05-22

  This study employs single-cell RNA sequencing and advanced histology to map the spatial and temporal expression of LRIG1 during murine salivary gland development. The findings clarify LRIG1's critical role in progenitor cell regulation and epithelial maturation, providing a molecular foundation for future research in glandular biology and tissue regeneration.

• Merimepodib (VX-497): Selective IMPDH Inhibitor for Antivira

  2026-05-21

  Merimepodib (VX-497) is a selective, noncompetitive, orally bioavailable inhibitor of inosine monophosphate dehydrogenase (IMPDH) with verified antiviral and immunosuppressive properties. Its mechanism blocks guanine nucleotide biosynthesis, impairing cell proliferation and viral replication. Recent studies confirm its effectiveness against diverse viruses and its role as a research tool in cancer and immunology.

• Decoding (S)-(+)-Ibuprofen: Selectivity, Mechanisms, and Adv

  2026-05-21

  (S)-(+)-Ibuprofen is a potent COX inhibitor central to inflammation pathway research. This article provides an advanced, mechanistic analysis and protocol guidance, surpassing surface-level usage guides and offering unique insights into synthesis, selectivity, and experimental design.

• Beclin1 Deficiency Reduces DOX-Induced Liver Injury via Ferr

  2026-05-20

  This study demonstrates that Beclin1 deficiency mitigates doxorubicin-induced hepatotoxicity by inhibiting both ferroptosis and autophagy pathways. The findings offer mechanistic insight into the regulation of oxidative stress in liver injury and highlight potential molecular targets for reducing chemotherapy-associated liver damage.

• Single-Molecule Screening of Fast-Dissociating Antibodies fo

  2026-05-20

  Miyoshi et al. developed a semi-automated single-molecule microscopy platform to directly screen for fast-dissociating yet specific monoclonal antibodies from hybridoma cultures. Their approach enables multiplex super-resolution imaging using Fab probes against epitope tags, with important implications for protein interaction and turnover studies.

• TMRE Mitochondrial Membrane Potential Assay Kit: Applied Wor

  2026-05-19

  The TMRE mitochondrial Membrane Potential Assay Kit empowers precise, high-throughput analysis of mitochondrial function and apoptosis, leveraging Tetramethylrhodamine ethyl ester for robust, reproducible results. Integrating recent mechanistic discoveries, this article details advanced use-cases, protocol enhancements, and troubleshooting strategies for maximizing assay reliability in cutting-edge mitochondrial research.

• Vitamin D Receptor Drives Ferroptosis-Linked Salivary Hypose

  2026-05-19

  This study uncovers that upregulation of the vitamin D receptor (VDR) promotes ferroptosis and impairs salivary secretion in female Sod1 knockout mice, linking oxidative stress, sex differences, and iron-dependent cell death. The findings offer new mechanistic insight into dry mouth pathogenesis and highlight ferroptosis as a promising target for therapeutic intervention.

• Vardenafil HCl Trihydrate: Enabling Proteoform-Resolved PDE5

  2026-05-18

  This thought-leadership article examines how Vardenafil HCl Trihydrate—APExBIO’s highly selective PDE5 inhibitor—empowers translational researchers to interrogate the mechanistic and proteoform-specific dynamics of cGMP signaling in smooth muscle systems. By bridging recent advances in native mass spectrometry and proteomics with practical PDE5 inhibition assays, we chart a new path for precision pharmacology in erectile dysfunction and vascular models.

16635 records 1/1109 page Next 12345 下5页 Last page